Remove deep-dive
article thumbnail

Deep Dive: Patients and Partnerships 2022

pharmaphorum

The concept of patient centricity has been a key talking point across the healthcare ecosystem for years. Having recognised the tangible benefits that their unique insights and experiences can bring to the table, decision-makers are increasingly seeking new opportunities to partner with patients across a product’s lifecycle.

article thumbnail

Deep Dive: Digital Health 2022

pharmaphorum

Read on for key stories from this year’s Frontiers Health conference in Italy, unlocking the promise of patient support programmes in oncology, supercharging communications with modular content, and much more. Unlocking the promise of patient support programmes in oncology. Read Deep Dive: Digital Health 2022 in full.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Deep Dive: Oncology 2022

pharmaphorum

As this issue’s contributors discuss, by working together pharma companies and healthcare providers can significantly enhance oncology treatment for patients. Read Deep Dive: Oncology in full. Subscribe to future issues of Deep Dive. The post Deep Dive: Oncology 2022 appeared first on.

article thumbnail

Deep Dive: Communications & Commercialisation 2022

pharmaphorum

Next generation patient engagement and enriched insights. As person generated health data becomes more widely recognised, a new whitepaper from Evidation explores how patient insights impact clinical decision making. Read Deep Dive: Communications & Commercialisation 2022 in full.

Pharma 52
article thumbnail

Exploring Pharmaceutical Sales Reps Salaries: A Deep Dive

Rep-Lite

Despite these challenges, pharmaceutical sales reps play a crucial role in driving revenue for their companies and promoting life-saving medication to patients. The post Exploring Pharmaceutical Sales Reps Salaries: A Deep Dive appeared first on Medical Staffing & Recruitment Agency.

article thumbnail

Pharmacovigilance deep dive: risk minimisation measures

European Pharmaceutical Review

This can be achieved by reducing the burden of adverse reactions or by optimising benefits through patient selection (eg, contraindications, recommendations of use, warnings, concomitant medicine[s], or certain test parameters) and treatment management (eg, specific dosing regimen, relevant testing, patient follow-up).

article thumbnail

PAP 2024: Examining Patient Access and Affordability

Pharmaceutical Commerce

Panel discusses PAN Foundation’s inaugural “State of Patient Access” report, and dives deep into patient challenges.